In the population of 147 patients with detectable ctDNA (i.e., with at least one variant detected), TP53 variants were more often found in younger, premenopausal patients with triple-negative or grade-3 breast cancers, with a higher number of metastatic sites or synchronous metastasis. The gene discussed is TP53; the disease is breast carcinoma.